CS logo
small CS logo
IPS Research Company

Oklahoma City, Oklahoma, United States
Research institute in Oklahoma City, Oklahoma
607 N Western Ave, Oklahoma City, OK 73106

About IPS Research Company


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shire
21
Forest Laboratories
9
Sunovion
9
Pfizer
8
Otsuka Pharmaceutical Development & Commercialization, Inc.
6
Allergan
5
Eli Lilly and Company
5
Janssen Research & Development, LLC
5
Naurex, Inc, an affiliate of Allergan plc
5
Akili Interactive Labs, Inc.
3
Biohaven Pharmaceuticals, Inc.
3
Total Rows: 54

Clinical Trials at IPS Research Company


During the past decade, IPS Research Company conducted 74 clinical trials. In the 10-year time frame, 74 clinical trials started and 66 clinical trials were completed, i.e. on average, 89.2% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 37 clinical trials were completed. i.e. 246.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2020111111111313444410101177115544121218187799Started TrialsCompleted Trails201520162017201820192020202120220102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
2003-05-01
2003-10-01
Completed
180
Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects During the Maintenance Phase of Bipolar Illness
2003-07-01
Terminated
180
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
2004-01-01
2006-07-01
Completed
328
Experimental Medication For the Treatment of Generalized Anxiety Disorder
2004-11-01
2005-12-01
Completed
511
A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
2005-03-01
2006-03-01
Completed
158
The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
2005-03-01
Completed
312
A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
2004-09-01
2007-01-01
Completed
443
A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
2004-09-01
2006-06-01
Completed
257

Rows per page:

1–100 of 139

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "IPS Research Company" #1 sponsor was "Shire" with 21 trials, followed by "Forest Laboratories" with 9 trials sponsored, "Sunovion" with 9 trials sponsored, "Pfizer" with 8 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 8 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 54 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "IPS Research Company" #1 collaborator was "Ironwood Pharmaceuticals, Inc." with 3 trials as a collaborator, "Allergan Sales, LLC" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShire: 21Shire: 21Forest Laboratories: 9Forest Laboratories: 9Sunovion: 9Sunovion: 9Pfizer: 8Pfizer: 8Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:6Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:6Allergan: 5Allergan: 5Eli Lilly and Company: 5Eli Lilly and Company: 5Janssen Research &Development, LLC: 5Janssen Research &Development, LLC: 5Naurex, Inc, an affiliateof Allergan plc: 5Naurex, Inc, an affiliateof Allergan plc: 5Akili Interactive Labs, Inc.: 3Akili Interactive Labs, Inc.: 3

Created with Highcharts 11.1.0Top CollaboratorsIronwoodPharmaceuticals, Inc.: 3IronwoodPharmaceuticals, Inc.: 3Allergan Sales, LLC: 2Allergan Sales, LLC: 2National Institute onAging (NIA): 2National Institute onAging (NIA): 2Purdue Pharma LP: 2Purdue Pharma LP: 2Amgen: 1Amgen: 1Banner Alzheimer's Institute: 1Banner Alzheimer's Institute: 1H. Lundbeck A/S: 1H. Lundbeck A/S: 1Medpace, Inc.: 1Medpace, Inc.: 1Novartis Vaccines: 1Novartis Vaccines: 1Noven Pharmaceuticals, Inc.: 1Noven Pharmaceuticals, Inc.: 1

Clinical Trials Conditions at IPS Research Company


According to Clinical.Site data, the most researched conditions in "IPS Research Company" are "Major Depressive Disorder" (21 trials), "Depressive Disorder, Major" (12 trials), "ADHD" (9 trials), "Attention Deficit Hyperactivity Disorder" (8 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (7 trials). Many other conditions were trialed in "IPS Research Company" in a lesser frequency.

Clinical Trials Intervention Types at IPS Research Company


Most popular intervention types in "IPS Research Company" are "Drug" (132 trials), "Other" (12 trials), "Biological" (5 trials), "Device" (2 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (65 trials), "Dasotraline" (6 trials), "Rapastinel" (5 trials), "placebo" (4 trials) and "Fluoxetine" (3 trials). Other intervention names were less common.

Clinical Trials Genders at IPS Research Company


The vast majority of trials in "IPS Research Company" are 136 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at IPS Research Company


Currently, there are NaN active trials in "IPS Research Company". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 109 completed trials in IPS Research Company, undefined suspended trials, and 18 terminated clinical trials to date.
Out of the total trials that were conducted in IPS Research Company, 3 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 90Phase 3: 90Phase 2: 42Phase 2: 42Phase 4: 8Phase 4: 8Not Applicable: 4Not Applicable: 4Phase 1: 3Phase 1: 3

Created with Highcharts 11.1.0Trials StatusCompleted: 109Completed: 109Terminated: 18Terminated: 18Recruiting: 7Recruiting: 7Active, not recruiting: 4Active, not recruiting: 4Enrolling by invitation: 1Enrolling by invitation: 1